Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Advertisement

Advertisement




May
15
Today In Oncology
Study Finds DLBCL Subtype May Have Higher Mortality Risk in Female Patients
Early Ovarian Cancer Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival
Relacorilant Plus Nab-Paclitaxel Improves Overall Survival in Platinum-Resistant Ovarian Cancer
Local Salvage Therapy for Post-Radiotherapy Local Recurrence of Prostate Cancer
Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo